Facts and Figures

Learn more about what makes the Icahn School of Medicine at Mount Sinai (ISMMS) a leader. Review data and background information about the School and our faculty, staff, and students. You can also find information on admissions, research, clinical care, and our partnerships and academic affiliations.

Who We Are

At ISMMS we train the physicians and scientists of tomorrow while we conduct breakthrough research and provide multidisciplinary clinical care.

Quick Facts

Academic Community

  • 561 medical students
  • 95 MD/PhD students
  • 279 PhD students
  • 356 master's degree students
  • 601 Postdoctoral Fellows

NIH Funding

  • $318.4 million in National Institutes of Health (NIH) funding awarded to our researchers in 2017
  • 13th among U.S. medical schools for NIH funding
  • 2nd in research dollars per principal investigator among U.S. medical schools by the Association of American Medical Colleges (AAMC)

*As of 2018

Since it opened in 1968, the School, led by Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai and President for Academic Affairs, Mount Sinai Health System, has become a world-class leader in medical education, research, and patient care.

  • Named #1 among “Top 12 Hospitals and Health Systems” by DiversityInc. in 2017
  • The School is made up of 36 multidisciplinary research, educational, and clinical Institutes and 33 academic Departments
  • Annual budget: $2.7 billion
  • Named 4th among “World’s Most Innovative Companies in Data Science” by Fast Company magazine in 2016
  • More than 6,369 full-time, part-time, and voluntary faculty
  • 5,640 people employed full-time by the School (excluding faculty)

For the 2017-2018 academic year:

  • 1,291 students enrolled in MD, PhD, MD/PhD, and master’s degree programs
    • 561 medical students
    • 95 MD/PhD students
    • 279 PhD students
    • 356 master's degree students
  • More than 2,000 residents and fellows
  • 601 postdoctoral candidates received progressive training
  • Students graduating with dual degrees
    • 11 dual MD/PhD graduates
    • 9 dual MD/MPH graduates
    • 4 dual MD/MSCR graduates
  • A diverse pool of students
    • MD Students:
      • Women: 50 percent
      • Underrepresented minorities: 17.1 percent
      • Age range: 21 to 36
    • Graduate Students
      • Women: 63 percent
      • Underrepresented minorities: 19.9 percent
      • Age range: 21 to 60

For the 2017-2018 academic year:

  • 6,935 applications received
    • 5,587 MD (including FlexMed) and MD/PhD applications
    • 1,348 graduate program applications
  • More than 1,000 interviews conducted
    • 863  MD and MD/PhD interviews                                
    • 204 graduate  interviews
  • 1,002 applications accepted
    • 452 MD and MD/PhD students
    • 550 graduate students
  • Most popular undergraduate majors for accepted students 
    • For MD and MD/PhD students : Biology, Neuroscience, Molecular Biology, and Biochemistry
    • For graduate students : Biology, Medicine, Psychology, Biochemistry, Biological Sciences, and Neuroscience
  • Average age of entering medical students: 23
  • Average age of entering grad students: 26
  • GPA and MCAT scores for admitted MD and MD/PhD candidates   
    • Matriculated median UGPA
      • 3.82 for MD students
      • 3.92 for  MD/PhD students        
    • Matriculated median MCAT 
      • 35 for MD students
      • 34 for  MD/PhD students 
  • GPA and GRE scores for admitted grad students 
    • Matriculated median UGPA: 3.37
    • Matriculated median GRE Verb: 158
    • Matriculated median GRE Quant: 158
    • Matriculated median Writing: 4

ANOTHER DAY, ANOTHER BREAKTHROUGH

Our investigators conduct groundbreaking research with funding support that moves discoveries from the bench to the bedside and from the lab to the marketplace.

  • $318.4 million in National Institutes of Health (NIH) funding awarded to our researchers in 2017
    • Ranked 13th among U.S. medical schools for NIH funding
    • Ranked 2nd in research dollars per principal investigator among U.S. medical schools by the Association of American Medical Colleges (AAMC)
  • Mount Sinai Innovation Partners helps bring many discoveries to market
    • 17 marketed products and technologies including FluMist vaccine, Fabrazyme®, a treatment for Fabry disease, and the Annuloplasty Ring, a device for repairing heart valves
    • 12 products currently in the development

Patients have access to care by physicians with expertise across a wide range of specialties in The Mount Sinai Health System’s network throughout the five boroughs and Long Island.

  • More than 2,000 physicians saw patients through our Mount Sinai Doctors Faculty Practice, a multi-specialty group practice across approximately 50 practice locations
  • 125 specialties within 29 clinical departments
  • Approximately 3.5 million annual physician visits to Mount Sinai Doctors Faculty Practice

History of the Icahn School of Medicine at Mount Sinai and Innovation